Skip to main content


Fig. 2 | BMC Infectious Diseases

Fig. 2

From: The potential of a multiplex high-throughput molecular assay for early detection of first and second line tuberculosis drug resistance mutations to improve infection control and reduce costs: a decision analytical modeling study

Fig. 2

One-way sensitivity analysis showing the magnitude of the effect of each listed parameter or assumption on Total costs, Nosocomial transmission months and Diagnostic cost per (pre-)XDR case detected. Legend: MRD = molecular resistance detection, FLQ = fluoroquinolones, SLID = injectable aminoglycosides, MDR = multi-drug resistance, defined as resistance to rifampicin and isoniazid, XDR = extensively drug-resistant. * indicates a change in ranking

Back to article page